Showing results (541-550 of 699) with videos related to
Sort By:
Pageof 70
Molecular Pharmaceutics|October 4, 2018
Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 AgonistsMichael A Collier, Robert D Junkins, Matthew D Gallovic, et al.Pharmacogenomics|November 19, 2013
Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapineBenjamin W J Spencer, Barbara Prainsack, Dan Rujescu, et al.Translational Psychiatry|October 14, 2015
Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophreniaA Ingason, I Giegling, A M Hartmann, et al.Molecular Psychiatry|March 10, 2004
Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotypeT Li, H Stefansson, E Gudfinnsson, et al.Nature Communications|October 26, 2018
Expression-based drug screening of neural progenitor cells from individuals with schizophreniaBenjamin Readhead, Brigham J Hartley, Brian J Eastwood, et al.Antimicrobial Agents and Chemotherapy|September 15, 2001
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adultsP Barditch-Crovo, S G Deeks, A Collier, et al.Neuroimage|March 23, 2011
Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controlsSergio Alessandro Papagni, Andrea Mechelli, Diana P Prata, et al.Nature Communications|November 20, 2018
Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophreniaBenjamin Readhead, Brigham J Hartley, Brian J Eastwood, et al.Cancer Chemotherapy and Pharmacology|May 10, 2000
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeksJ D Roberts, S Shibata, D V Spicer, et al.Psychological Medicine|February 28, 2013
White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatmentQ Wang, C Cheung, W Deng, et al.Pageof 70